Skip to content

Nasdaq · CIK 0001815776

LENZ LENZ Therapeutics, Inc.

Insider trading from SEC Form 4. Last filing Nov 7, 2025.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company

Signals

Open-market buys and sells at LENZ Therapeutics, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
39WeakDaniel R. Chevallard
Chief Financial Officer
buy
$50k
2,198 shares
+69%-
42ModerateVersant Venture Capital VI, L.P.
owner
sell
$5.7M
135,304 shares
-11%-
42ModerateVersant Venture Capital VI, L.P.
owner
sell
$7.4M
188,094 shares
-13%-
42ModerateVersant Venture Capital VI, L.P.
owner
sell
$10M
260,713 shares
-17%-
42ModerateVersant Venture Capital VI, L.P.
owner
sell
$6.5M
191,376 shares
-11%-
42ModerateVersant Venture Capital VI, L.P.
owner
sell
$6.1M
200,000 shares
-10%-
47ModerateVersant Venture Capital VI, L.P.
owner
sell
$10M
334,801 shares
-27%-
42ModerateVersant Venture Capital VI, L.P.
owner
sell
$10M
350,000 shares
-22%-

Transactions

The last 47 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Nov 7, 2025Daniel R. Chevallard
Chief Financial Officer
POpen-market purchase
Common Stock
+20$22.71$4543,208Nov 7, 2025
Nov 7, 2025Daniel R. Chevallard
Chief Financial Officer
POpen-market purchase
Common Stock
+2,178$22.76$50k5,386Nov 7, 2025
Sep 18, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-49,479$41.59$2.1M1,224,718Sep 22, 2025
Sep 18, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-24,370$41.59$1.0M876,437Sep 22, 2025
Sep 18, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-40,907$43.00$1.8M1,183,811Sep 22, 2025
Sep 18, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-20,148$43.00$866k856,289Sep 22, 2025
Sep 18, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-268$43.30$12k1,183,543Sep 22, 2025
Sep 18, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-132$43.30$5,716856,157Sep 22, 2025
Aug 22, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-20,493$40.03$820k1,379,727Aug 26, 2025
Aug 22, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-10,076$40.03$403k952,802Aug 26, 2025
Aug 22, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-5,668$40.59$230k1,374,059Aug 26, 2025
Aug 22, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-2,809$40.59$114k949,993Aug 26, 2025
Aug 25, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-50,270$39.53$2.0M1,323,789Aug 26, 2025
Aug 25, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-24,760$39.53$979k925,233Aug 26, 2025
Aug 25, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-2,149$39.92$86k1,321,640Aug 26, 2025
Aug 25, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-1,058$39.92$42k924,175Aug 26, 2025
Aug 26, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-43,978$38.97$1.7M1,277,662Aug 26, 2025
Aug 26, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-21,661$38.97$844k902,514Aug 26, 2025
Aug 26, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-3,465$39.50$137k1,274,197Aug 26, 2025
Aug 26, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-1,707$39.50$67k900,807Aug 26, 2025
Aug 15, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-145,051$39.50$5.7M1,430,848Aug 19, 2025
Aug 15, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-69,949$39.50$2.8M977,963Aug 19, 2025
Aug 18, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-30,628$38.56$1.2M1,400,220Aug 19, 2025
Aug 18, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See Footnote
-15,085$38.56$582k962,878Aug 19, 2025
Jul 10, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-191,376$34.00$6.5M1,575,899Jul 14, 2025
Jun 27, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-200,000$30.47$6.1M1,767,275Jul 1, 2025
Jun 18, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See footnote
-100,000$29.95$3.0M1,148,789Jun 20, 2025
Jun 20, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See footnote
-100,877$30.35$3.1M1,047,912Jun 20, 2025
Jun 20, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stock
-133,924$30.25$4.1M1,967,275Jun 20, 2025
Jun 10, 2025Versant Venture Capital VI, L.P.
owner
SOpen-market sale
Common Stockindirect: See footnote
-350,000$29.00$10M1,248,789Jun 12, 2025
Jun 11, 2025James W McCollum
director
AGrant or award
Stock Option (right to buy)derivative
+13,500$0.00$013,500Jun 11, 2025
Jun 11, 2025Shelley B Thunen
director
AGrant or award
Stock Option (right to buy)derivative
+13,500$0.00$013,500Jun 11, 2025
Jun 11, 2025Zachary Scheiner
director
AGrant or award
Stock Option (right to buy)derivative
+13,500$0.00$013,500Jun 11, 2025
Jun 11, 2025Ra Capital Management, L.p.
director, owner
AGrant or award
Stock Option (right to buy)derivativeindirect: See footnotes
+13,500$0.00$013,500Jun 11, 2025
Jun 11, 2025Frederic Guerard
director
AGrant or award
Stock Option (right to buy)derivative
+13,500$0.00$013,500Jun 11, 2025
Jun 11, 2025Jeffrey P. George
director
AGrant or award
Stock Option (right to buy)derivative
+13,500$0.00$013,500Jun 11, 2025
Jun 11, 2025Kimberlee C Drapkin
director
AGrant or award
Stock Option (right to buy)derivative
+13,500$0.00$013,500Jun 11, 2025
Apr 9, 2025Shawn Olsson
Chief Commercial Officer
MOption exercise
Common Stock
+1,400$2.08$2,9124,733Apr 9, 2025
Apr 9, 2025Shawn Olsson
Chief Commercial Officer
MOption exercise
Stock Option (right to buy)derivative
-1,400$0.00$063,241Apr 9, 2025
Mar 7, 2025Evert B. Schimmelpennink
President, CEO and Secretary
MOption exercise
Common Stock
+4,200$1.04$4,36849,200Mar 7, 2025
Mar 7, 2025Evert B. Schimmelpennink
President, CEO and Secretary
MOption exercise
Stock Option (right to buy)derivative
-4,200$0.00$0337,906Mar 7, 2025
Jan 9, 2025Daniel R. Chevallard
Chief Financial Officer
AGrant or award
Stock Option (right to buy)derivative
+70,444$0.00$070,444Jan 13, 2025
Jan 9, 2025Evert B. Schimmelpennink
President, CEO and Secretary
AGrant or award
Stock Option (right to buy)derivative
+279,100$0.00$0279,100Jan 13, 2025
Jan 9, 2025Marc Odrich
Chief Medical Officer
AGrant or award
Stock Option (right to buy)derivative
+80,100$0.00$080,100Jan 13, 2025
Jan 9, 2025Shawn Olsson
Chief Commercial Officer
AGrant or award
Stock Option (right to buy)derivative
+80,100$0.00$080,100Jan 13, 2025
Dec 16, 2024Shawn Olsson
Chief Commercial Officer
MOption exercise
Common Stock
+3,333$2.08$6,9333,333Dec 17, 2024
Dec 16, 2024Shawn Olsson
Chief Commercial Officer
MOption exercise
Stock Option (right to buy)derivative
-3,333$0.00$064,641Dec 17, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

LENZ insider trading: LENZ Therapeutics, Inc. | InsiderTell